Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ANXIOLYTIC DRUGS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 60 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Venault, P; Rudrauf, D; Lepicard, EM; Berthoz, A; Jouvent, R; Chapouthier, G
      Balance control and posture in anxious mice improved by SSRI treatment

      NEUROREPORT
    2. da Silva, AL; Elisabetsky, E
      Interference of propylene glycol with the hole-board test

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    3. Olaman, SJ; McNaughton, N
      Chlordiazepoxide specifically impairs nonspatial reference memory in the cued radial arm maze in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    4. Griebel, G; Perrault, G; Soubrie, P
      Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents

      PSYCHOPHARMACOLOGY
    5. Merlo, J; Ostergren, PO; Mansson, NO; Hanson, BS; Ranstam, J; Blennow, G; Isacsson, SO; Melander, A
      Mortality in elderly men with low psychosocial coping resources using anxiolytic-hypnotic drugs

      SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
    6. Farde, L; Andree, B; Ginovart, N; Halldin, C; Thorberg, SO
      PET-determination of robalzotan (NAD-299) induced 5-HT1A receptor occupancy in the monkey brain

      NEUROPSYCHOPHARMACOLOGY
    7. Mahe, V; Balogh, A
      Long-term pharmacological treatment of generalized anxiety disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    8. Bourin, M
      Clinical methodology for testing of anxiolytic drugs

      THERAPIE
    9. Gleason, SD; Leander, JD
      Influence of light cycle on response to 5-HT1A ligands in punished responding in rats

      BEHAVIOURAL PHARMACOLOGY
    10. Griebel, G; Perrault, G; Tan, S; Schoemaker, H; Sanger, DJ
      Pharmacological studies on synthetic flavonoids: comparison with diazepam

      NEUROPHARMACOLOGY
    11. Kleven, MS; Koek, W
      Effects of different classes of partial benzodiazepine agonists on punished and unpunished responding in pigeons

      PSYCHOPHARMACOLOGY
    12. Kleven, MS; Koek, W
      Effects of benzodiazepine agonists on punished responding in pigeons and their relationship with clinical doses in humans

      PSYCHOPHARMACOLOGY
    13. FLORES P; PELLON R
      EFFECTS OF D-AMPHETAMINE, DIAZEPAM AND BUSPIRONE ON SCHEDULE-INDUCED-POLYDIPSIA SUPPRESSED BY RESPONSE-DEPENDENT AND RESPONSE-INDEPENDENT SHOCK

      Behavioural pharmacology
    14. KARLE J; NIELSEN M
      THE MECHANISM OF ACTION AND PHARMACOLOGY OF ZOPICLONE

      Reviews in contemporary pharmacotherapy
    15. File, SE; Kenny, PJ; Ouagazzal, AM
      Bimodal modulation by nicotine of anxiety in the social interaction test: Role of the dorsal hippocampus

      BEHAVIORAL NEUROSCIENCE
    16. KANT GJ; WYLIE RM; CHU K; GHOSH S
      EFFECTS OF THE SEROTONIN AGONISTS 8-OH-DPAT, BUSPIRONE, AND DOI ON WATER MAZE PERFORMANCE

      Pharmacology, biochemistry and behavior
    17. OLIVIER B; MOLEWIJK E; VANOORSCHOT R; VANDERHEYDEN J; RONKEN E; MOS J
      RAT PUP ULTRASONIC VOCALIZATION - EFFECTS OF BENZODIAZEPINE RECEPTOR LIGANDS

      European journal of pharmacology
    18. DUGAST C; SOULIERE F; SCHMITT P; CASANOVAS JM; FATTACCINI CM; MOCAER E; LESOURD M; RENAUD B; ARTIGAS F; HAMON M; CHOUVET G
      IS THE POTENT 5-HT1A RECEPTOR AGONIST, ALNESPIRONE (S-20499), AFFECTING DOPAMINERGIC SYSTEMS IN THE RAT-BRAIN

      European journal of pharmacology
    19. MARTIN P
      ANIMAL-MODELS SENSITIVE TO ANTI-ANXIETY AGENTS

      Acta psychiatrica Scandinavica
    20. GRIEBEL G; PERRAULT G; SANGER DJ
      CHARACTERIZATION OF THE BEHAVIORAL PROFILE OF THE NON PEPTIDE CRF RECEPTOR ANTAGONIST CP-154,526 IN ANXIETY MODELS IN RODENTS - COMPARISON WITH DIAZEPAM AND BUSPIRONE

      Psychopharmacology
    21. RODGERS RJ
      ANIMAL-MODELS OF ANXIETY - WHERE NEXT

      Behavioural pharmacology
    22. LINDEN M; HADLER D; HOFMANN S
      RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE EFFICACY AND TOLERABILITY OF A NEW ISOINDOLINE DERIVATIVE (DN-2327) IN GENERALIZED ANXIETY

      Human psychopharmacology
    23. GEIST TD; ETTENBERG A
      CONCURRENT POSITIVE AND NEGATIVE GOALBOX EVENTS PRODUCE RUNWAY BEHAVIORS COMPARABLE TO THOSE OF COCAINE-REINFORCED RATS

      Pharmacology, biochemistry and behavior
    24. MCNAUGHTON N
      COGNITIVE DYSFUNCTION RESULTING FROM HIPPOCAMPAL HYPERACTIVITY - A POSSIBLE CAUSE OF ANXIETY DISORDER

      Pharmacology, biochemistry and behavior
    25. TRAPANI G; FRANCO M; RICCIARDI L; LATROFA A; GENCHI G; SANNA E; TUVERI F; CAGETTI E; BIGGIO G; LISO G
      SYNTHESIS AND BINDING-AFFINITY OF 2-PHENYLIMIDAZO[1,2-A]PYRIDINE DERIVATIVES FOR BOTH CENTRAL AND PERIPHERAL BENZODIAZEPINE RECEPTORS - A NEW SERIES OF HIGH-AFFINITY AND SELECTIVE LIGANDS FOR THE PERIPHERAL-TYPE

      Journal of medicinal chemistry
    26. KING CMF; GOMMANS J; JOORDENS RJE; HIJZEN TH; MAES RAA; OLIVIER B
      EFFECTS OF 5-HT1A RECEPTOR LIGANDS IN A MODIFIED GELLER-SEIFTER CONFLICT MODEL IN THE RAT

      European journal of pharmacology
    27. BALLAZ S; BARBER A; FORTUNO A; DELRIO J; MARTINMARTINEZ M; GOMEZMONTERREY I; HERRANZ R; GONZALEZMUNIZ R; GARCIALOPEZ MT
      PHARMACOLOGICAL EVALUATION OF IQM-95,333, A HIGHLY SELECTIVE CCKA RECEPTOR ANTAGONIST WITH ANXIOLYTIC-LIKE ACTIVITY IN ANIMAL-MODELS

      British Journal of Pharmacology
    28. BROOCKS A; BRIGGS NC; PIGOTT TA; HILL JL; CANTER SK; TOLLIVER TJ; BALDEMORE D; MURPHY DL
      BEHAVIORAL, PHYSIOLOGICAL AND NEUROENDOCRINE RESPONSES IN HEALTHY-VOLUNTEERS TO M-CHLOROPHENYLPIPERAZINE (M-CPP) WITH AND WITHOUT ONDANSETRON PRETREATMENT

      Psychopharmacology
    29. BENVENGA MJ; LEANDER JD
      ANTICONFLICT EFFECTS OF 5HT(1A) AGONISTS IN PIGEONS ARE DEPENDENT ON THE LEVEL OF RESPONSE SUPPRESSION

      Behavioural pharmacology
    30. LUCKI I
      SEROTONIN RECEPTOR SPECIFICITY IN ANXIETY DISORDERS

      The Journal of clinical psychiatry
    31. GRIEBEL G; BLANCHARD DC; RETTORI MC; GUARDIOLALEMAITRE B; BLANCHARD RJ
      PRECLINICAL PROFILE OF THE MIXED 5-HT1A 5-HT2A RECEPTOR ANTAGONIST S21357/

      Pharmacology, biochemistry and behavior
    32. MCNAUGHTON N; PANICKAR KS; LOGAN B
      THE PITUITARY-ADRENAL AXIS AND THE DIFFERENT BEHAVIORAL-EFFECTS OF BUSPIRONE AND CHLORDIAZEPOXIDE

      Pharmacology, biochemistry and behavior
    33. WITKIN JM; ACRI JB; WONG G; GLEESON S; BARRETT JE
      BEHAVIORAL AND BIOCHEMICAL-CHARACTERIZATION OF BENZODIAZEPINE RECEPTOR PARTIAL AGONISTS IN PIGEONS

      The Journal of pharmacology and experimental therapeutics
    34. DALVI A; RODGERS RJ
      GABAERGIC INFLUENCES ON PLUS-MAZE BEHAVIOR IN MICE

      Psychopharmacology
    35. MCNAUGHTON N; LOGAN B; PANICKAR KS; KIRK IJ; PAN WX; BROWN NT; HEENAN A
      CONTRIBUTION OF SYNAPSES IN THE MEDIAL SUPRAMAMMILLARY NUCLEUS TO THEFREQUENCY OF HIPPOCAMPAL-THETA RHYTHM IN FREELY MOVING RATS

      Hippocampus
    36. ZHU XO; MCNAUGHTON N
      SIMILAR EFFECTS OF BUSPIRONE AND CHLORDIAZEPOXIDE ON A FIXED-INTERVALSCHEDULE WITH LONG-TERM, LOW-DOSE ADMINISTRATION

      JOURNAL OF PSYCHOPHARMACOLOGY
    37. PATAT A; PERAULT MC; VANDEL B; DANJOU P; BROHIER S; ZIELENIUK I; ROSENZWEIG P
      ASSESSMENT OF THE INTERACTION BETWEEN A PARTIAL AGONIST AND A FULL AGONIST OF BENZODIAZEPINE RECEPTORS, BASED ON PSYCHOMOTOR PERFORMANCE AND MEMORY, IN HEALTHY-VOLUNTEERS

      JOURNAL OF PSYCHOPHARMACOLOGY
    38. RODGERS RJ; JOHNSON NJT; NORTON SJ; COLE JC
      EFFECTS OF RITANSERIN AND 1-(2,5-DIMETHOXY-4-IODOPHENYL)-2-AMINOPROPANE (DOI) IN THE MURINE ELEVATED PLUS-MAZE TEST OF ANXIETY - AN ETHOPHARMACOLOGICAL STUDY

      JOURNAL OF PSYCHOPHARMACOLOGY
    39. ZHU XO; MCNAUGHTON N
      EFFECTS OF LONG-TERM ADMINISTRATION OF PHENELZINE ON RETICULAR-ELICITED HIPPOCAMPAL RHYTHMICAL SLOW ACTIVITY

      Neuroscience research
    40. MCNAUGHTON N
      BRAIN MECHANISMS OF ANXIETY

      New Zealand journal of psychology
    41. BENVENGA MJ; ORNSTEIN PL; LEANDER JD
      SCHEDULE-CONTROLLED BEHAVIORAL-EFFECTS OF THE SELECTIVE AMINO-3-(5-METHYL-3-HYDROXYISOXAZOL-4-YL)PROPANOIC ACID ANTAGONIST LY293558 IN PIGEONS

      The Journal of pharmacology and experimental therapeutics
    42. FREO U; PIETRINI P; PIZZOLATO G; FUREYKURKJIAN M; MERICO A; RUGGERO S; DAM M; BATTISTIN L
      DOSE-DEPENDENT EFFECTS OF BUSPIRONE ON BEHAVIOR AND CEREBRAL GLUCOSE-METABOLISM IN RATS

      Brain research
    43. BENVENGA MJ; LEANDER JD
      OLANZAPINE, AN ATYPICAL ANTIPSYCHOTIC, INCREASES RATES OF PUNISHED RESPONDING IN PIGEONS

      Psychopharmacology
    44. MOLEWIJK HE; VANDERPOEL AM; MOS J; VANDERHEYDEN JAM; OLIVIER B
      CONDITIONED ULTRASONIC DISTRESS VOCALIZATIONS IN ADULT MALE-RATS AS ABEHAVIORAL PARADIGM FOR SCREENING ANTI-PANIC DRUGS

      Psychopharmacology
    45. LADER M
      ANXIOLYTIC DRUGS - DEPENDENCE, ADDICTION AND ABUSE

      European neuropsychopharmacology
    46. EISON AS; EISON MS
      SEROTONERGIC MECHANISMS IN ANXIETY

      Progress in neuro-psychopharmacology & biological psychiatry
    47. MOORE MS; KUENZEL WJ; MENCH JA
      A TECHNIQUE FOR CANNULATING THE CISTERNA-MAGNA AND SAMPLING CEREBROSPINAL-FLUID FROM SOCIALLY HOUSED BIRDS

      Poultry science
    48. GREENBLATT DJ; HARTMATZ JS; GOUTHRO TA; LOCKE J; SHADER RI
      DISTINGUISHING A BENZODIAZEPINE AGONIST (TRIAZOLAM) FROM A NONAGONISTANXIOLYTIC (BUSPIRONE) BY ELECTROENCEPHALOGRAPHY - KINETIC-DYNAMIC STUDIES

      Clinical pharmacology and therapeutics
    49. BARRETT JE; GAMBLE EH; ZHANG L; GUARDIOLALEMAITRE B
      ANTICONFLICT AND DISCRIMINATIVE STIMULUS EFFECTS IN THE PIGEON OF A NEW METHOXY-CHROMAN 5-HT1A AGONIST, (-20244 AND ITS ENANTIOMERS (+)S-20499 AND (-)S-20500()S)

      Psychopharmacology
    50. ZHU XO; MCNAUGHTON N
      A COMPARISON OF THE ACUTE EFFECTS OF A TRICYCLIC AND A MAOI ANTIDEPRESSANT ON SEPTAL DRIVING OF HIPPOCAMPAL RHYTHMICAL SLOW ACTIVITY

      Psychopharmacology
    51. GALIZIO M; HALE KL; LIBORIO MO; MILLER M
      VARIABLE-RATIO SCHEDULES OF TIMEOUT FROM AVOIDANCE - EFFECTS OF ANXIOLYTIC DRUGS

      Behavioural pharmacology
    52. NADER MA; HANNEMANN M
      INTERACTIONS OF BUSPIRONE OR GEPIRONE WITH NICOTINE ON SCHEDULE-CONTROLLED BEHAVIOR OF PIGEONS

      Behavioural pharmacology
    53. SIMIAND J; KEANE PE; BARNOUIN MC; KEANE M; SOUBRIE P; LEFUR G
      NEUROPSYCHOPHARMACOLOGICAL PROFILE IN RODENTS OF SR 57746A, A NEW, POTENT 5-HT(1A) RECEPTOR AGONIST

      Fundamental and clinical pharmacology
    54. WILEY JL; COMPTON AD; PORTER JH
      EFFECTS OF 4 ANTIPSYCHOTICS ON PUNISHED RESPONDING IN RATS

      Pharmacology, biochemistry and behavior
    55. AMANO M; GOTO A; SAKAI A; ACHIHA M; TAKAHASHI N; HARA C; OGAWA N
      COMPARISON OF THE ANTICONFLICT EFFECT OF BUSPIRONE AND ITS MAJOR METABOLITE 1-(2-PYRIMIDINYL)-PIPERAZINE (1-PP) IN RATS

      Japanese Journal of Pharmacology
    56. DEVRY J; BENZ U; SCHREIBER R; TRABER J
      SHOCK-INDUCED ULTRASONIC VOCALIZATION IN YOUNG-ADULT RATS - A MODEL FOR TESTING PUTATIVE ANTI-ANXIETY DRUGS

      European journal of pharmacology
    57. HORVATH EJ; HUDAK J; PALKOVITS M; LENKEI Z; FEKETE MIK; ARANYI P
      A NOVEL SPECIFIC BINDING-SITE FOR HOMOPHTHALAZINES IN THE RAT-BRAIN

      European journal of pharmacology
    58. BARRETT JE; VANOVER KE
      5-HT RECEPTORS AS TARGETS FOR THE DEVELOPMENT OF NOVEL ANXIOLYTIC DRUGS - MODELS, MECHANISMS AND FUTURE-DIRECTIONS

      Psychopharmacology
    59. WOJNICKI FHE; BARRETT JE
      ANTICONFLICT EFFECTS OF BUSPIRONE AND CHLORDIAZEPOXIDE IN PIGEONS UNDER A CONCURRENT SCHEDULE WITH PUNISHMENT AND A CHANGEOVER RESPONSE

      Psychopharmacology
    60. GYERTYAN I
      ANIMAL-MODELS OF ANXIETY - A CRITICAL-REVIEW

      Acta physiologica Hungarica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 02:46:47